loader

Delcath Systems

NASDAQ:DCTH

Delcath Systems Inc is an oncology company. It is focused on the treatment of primary and metastatic liver cancers.

Featured Articles and Interviews

How to Invest in Medical Device Stocks and ETFs

Press Releases

Delcath Systems, Inc. Announces Inducement Grants Under Nasdaq Listing Rule 5635

Delcath Systems to Participate in Upcoming Investor Conferences

Delcath Systems Announces First Patient Dosed in Phase 2 Clinical Trial of HEPZATO in Liver-Dominant Metastatic Colorectal Cancer

Delcath Systems Inc is an oncology company. It is focused on the treatment of primary and metastatic liver cancers. The firm's product candidate, Melphalan Hydrochloride for Injection for use with the Delcath Hepatic Delivery System, or Melphalan/HDS, is designed to administer high-dose chemotherapy to the liver while controlling systemic exposure and associated side effects.

Interactive Chart